IBM Forecast, price target & analysts
IBM Target price 2026 - Analyst rating & recommendation
IBM Classifications & Recommendation
IBM Price Target
| Target Price | $261.11 |
| Price | $247.11 |
| Potential | 5.67% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target IBM 2027 . The average IBM target price is $261.11. This is 5.67% higher than the current stock price. The highest price target is $367.50 48.72% , the lowest is $175.74 28.88% . | |
| A rating was issued by 31 analysts: 16 Analysts recommend IBM to buy, 13 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the IBM stock has an average upside potential 2027 of 5.67% . Most analysts recommend the IBM stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
27 Analysts have issued a sales forecast IBM 2026 . The average IBM sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
18 Analysts have issued an IBM EBITDA forecast 2026. The average IBM EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
28 IBM Analysts have issued a net profit forecast 2026. The average IBM net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Current IBM Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 22 2026 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 22 2026 |
| BMO Capital |
Market Perform
➜
Market Perform
|
Unchanged | Oct 22 2026 |
| Jefferies |
Buy
➜
Buy
|
Unchanged | Oct 22 2026 |
| Baird |
Neutral
➜
Neutral
|
Unchanged | Oct 22 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 22 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 22 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Oct 22 2026 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 22 2026 |
|
Unchanged
BMO Capital:
Market Perform
➜
Market Perform
|
Oct 22 2026 |
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Oct 22 2026 |
|
Unchanged
Baird:
Neutral
➜
Neutral
|
Oct 22 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 22 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 22 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
